EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of SKI-II as a host-protective immunomodulator against Staphylococcus aureus infection

Liyang Zhang iD, Kai Ye, Charilaos Dellis, Lewis Oscar Felix, Narchonai Ganesan, Biswajit Mishra, Aijun Zhang iD, Dale J Hamilton, Yizhi Jane Tao iD, Eleftherios Mylonakis iD

mBio · 2026

DOI: 10.1128/mbio.01558-26 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mBio, 2026. Verfasst von Liyang Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Houston Methodist Hospital, Houston, Texas, USA. Hauptthemen laut MEDLINE: Caenorhabditis elegans, Staphylococcal Infections, Staphylococcus aureus, Immunologic Factors. Die Arbeit nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antibiotic resistance threatens the effectiveness of conventional antimicrobial agents, underscoring the need for host-directed therapies that enhance immune defense. Here, we present a cross-species discovery pipeline that couples a Caenorhabditis elegans–Staphylococcus aureus liquid-based infection screen with mammalian mechanistic validation to identify small-molecule immunomodulators. Using six C. elegans innate immunity reporter strains, we identified a known small molecule, SKI-II, as a previously unrecognized host-protective compound that activates the C. elegans SKN-1/Nrf2 oxidative-stress pathway. In mouse RAW264.7 macrophages, SKI-II binds to the ATPase pocket of VCP (Valosin-Containing Protein), activating the PERK-dependent (Protein kinase R [PKR]-like Endoplasmic Reticulum Kinase) Nrf2 signaling regulation axis that reduces the levels of pathogenic ROS (reactive oxygen species). SKI-II treatment also promotes macrophage M1 polarization and a mitochondrial metabolic shift. This work identifies VCP as a druggable node for host-directed immunomodulation and highlights SKI-II as a prototype small molecule that boosts host tolerance to infection, thereby validating our C. elegans -based screening platform for discovering immunomodulators active in mammalian systems. IMPORTANCE Enhancing host immunity is a promising strategy to combat S. aureus infection, particularly multidrug-resistant strains. In this study, we applied a C. elegans liquid-based infection screening model to identify the immunomodulatory compound SKI-II. We demonstrate that SKI-II protects against S. aureus infection in both nematodes and mouse macrophages by regulating host oxidative stress pathways rather than directly targeting the pathogen. We reveal a regulatory circuit in which VCP functions as a central node controlling cellular ROS responses and activating the downstream PERK-dependent Nrf2 antioxidant signaling pathway. These findings advance our understanding of host cellular responses to bacterial infection and highlight VCP as a druggable target for host-directed therapeutic strategies against infectious diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Caenorhabditis elegansStaphylococcal InfectionsStaphylococcus aureusImmunologic FactorsImmunomodulating AgentsAnimalsMiceMacrophagesImmunity, InnateCaenorhabditis elegans ProteinsNF-E2-Related Factor 2RAW 264.7 CellsSignal TransductionOxidative StressDNA-Binding ProteinsValosin Containing ProteinHost-Directed TherapyTranscription FactorsReactive Oxygen Species

Stichwörter der Autor:innen

Caenorhabditis elegansNrf2SKI-IIStaphylococcus aureusimmunomodulation

Substanzen

Immunologic FactorsCaenorhabditis elegans ProteinsNF-E2-Related Factor 2skn-1 protein, C elegansDNA-Binding ProteinsValosin Containing ProteinTranscription FactorsReactive Oxygen SpeciesImmunomodulating Agents

Autor:innen und Institutionen

  • Department of Medicine, Houston Methodist Hospital, Houston, Texas, USA.
  • Department of BioSciences, Rice University, Houston, Texas, USA.
  • Department of Medicine, Weill Cornell Medical College, New York, New York, USA.

ORCID-Profile: Liyang Zhang, Aijun Zhang, Yizhi Jane Tao, Eleftherios Mylonakis

Förderung

  • NIAID NIH HHS

Zitieren

APA

Zhang, L., Ye, K., Dellis, C., Felix, L. O., Ganesan, N., Mishra, B., Zhang, A., Hamilton, D. J., Tao, Y. J., & Mylonakis, E. (2026). Identification of SKI-II as a host-protective immunomodulator against Staphylococcus aureus infection. mBio. https://doi.org/10.1128/mbio.01558-26

Vancouver

Zhang L, Ye K, Dellis C, Felix LO, Ganesan N, Mishra B, et al. Identification of SKI-II as a host-protective immunomodulator against Staphylococcus aureus infection. mBio. 2026. doi:10.1128/mbio.01558-26

BibTeX
@article{Zhang2026,
  author = {Zhang, Liyang and Ye, Kai and Dellis, Charilaos and Felix, Lewis Oscar and Ganesan, Narchonai and Mishra, Biswajit and Zhang, Aijun and Hamilton, Dale J and Tao, Yizhi Jane and Mylonakis, Eleftherios},
  title = {Identification of SKI-II as a host-protective immunomodulator against Staphylococcus aureus infection},
  journal = {mBio},
  year = {2026},
  doi = {10.1128/mbio.01558-26}
}
Kostenlos starten →